Skip to main content

EMEA News

By Tammy Lovell | 05:29 am | June 29, 2020
The firms are collaborating to launch a digital medication management and lifestyle platform across Europe.  
By Ahmed El Sherif | 09:22 am | June 25, 2020
The two companies have partnered to provide the tool, which works by guiding travellers through an AI-powered assessment based on WHO guidelines.
By Sophie Porter | 02:43 am | June 25, 2020
The scanner, which can read up to six people’s temperature at once, could be used to protect workers from COVID-19.
By Sara Mageit | 11:40 am | June 24, 2020
The Health Service Executive in Ireland has indicated that the COVID-19 tracker app will be downloadable from Google and Apple app stores, subject to final government approval.
By Philipp Grätzel von Grätz | 07:36 am | June 24, 2020
Infection surveillance and infection control are part of what makes countries successful that manage to keep the SarsCoV2 pandemic in check. Properly implemented, digital solutions can help a lot with testing, tracing and isolating. Striking the right balance between meeting public health requirements and upholding privacy is not easy though. 
By Sara Mageit | 05:23 am | June 24, 2020
Pagabo and Moodbeam have collaborated to aid mental health and wellbeing and improve working conditions in the construction sector.
By Tammy Lovell | 05:22 am | June 23, 2020
The proceeds will be used to further develop its technology which transforms clinical text into data.
By Ahmed El Sherif | 10:00 am | June 19, 2020
In a new investigation by Amnesty International, the two Gulf states and Norway have released apps that reportedly operate as mass surveillance tools.
By Piers Ford | 09:25 am | June 19, 2020
Demand for tech solutions has soared in Finland during the pandemic as healthcare providers seek new ways to diagnose and treat patients, and source properly tested PPE.
By Sara Mageit | 05:06 am | June 19, 2020
Also, Medwise.ai wins UK grant to develop AI-powered question answering platform for healthcare professionals during COVID-19.